112 related articles for article (PubMed ID: 16371933)
1. Dimeric but not monomeric soluble CD40 prolongs allograft survival and generates regulatory T cells that inhibit CTL function.
Masunaga T; Yamashita K; Sakihama H; Hashimoto T; Hua N; Imai A; Inobe M; Miyazaki T; Todo S; Uede T
Transplantation; 2005 Dec; 80(11):1614-22. PubMed ID: 16371933
[TBL] [Abstract][Full Text] [Related]
2. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
[TBL] [Abstract][Full Text] [Related]
3. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
[TBL] [Abstract][Full Text] [Related]
4. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation.
Nomura M; Yamashita K; Murakami M; Takehara M; Echizenya H; Sunahara M; Kitagawa N; Fujita M; Furukawa H; Uede T; Todo S
Transplantation; 2002 May; 73(9):1403-10. PubMed ID: 12023617
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
Chang GJ; Liu T; Feng S; Bedolli M; O'rourke RW; Schmidt G; Roberts JP; Stock PG
Surgery; 2002 Aug; 132(2):149-56. PubMed ID: 12219005
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
7. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model.
Kanaya K; Tsuchida Y; Inobe M; Murakami M; Hirose T; Kon S; Kawaguchi S; Wada T; Yamashita T; Ishii S; Uede T
Transplantation; 2003 Feb; 75(3):275-81. PubMed ID: 12589145
[TBL] [Abstract][Full Text] [Related]
8. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
Guillonneau C; Hill M; Hubert FX; Chiffoleau E; Hervé C; Li XL; Heslan M; Usal C; Tesson L; Ménoret S; Saoudi A; Le Mauff B; Josien R; Cuturi MC; Anegon I
J Clin Invest; 2007 Apr; 117(4):1096-106. PubMed ID: 17404623
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade.
Wang Y; Dai H; Liu Z; Cheng X; Tellides G; Dai Z
Am J Transplant; 2006 Dec; 6(12):2851-60. PubMed ID: 17062001
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
11. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
12. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
13. Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft.
Jin YZ; Xie SS
Transplant Proc; 2003 Dec; 35(8):3165-6. PubMed ID: 14698004
[TBL] [Abstract][Full Text] [Related]
14. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
15. Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells.
Fried A; Berg M; Sharma B; Bonde S; Zavazava N
J Leukoc Biol; 2005 Sep; 78(3):595-604. PubMed ID: 16000395
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.
Guillonneau C; Séveno C; Dugast AS; Li XL; Renaudin K; Haspot F; Usal C; Veziers J; Anegon I; Vanhove B
J Immunol; 2007 Dec; 179(12):8164-71. PubMed ID: 18056359
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenografts.
Hua N; Yamashita K; Hashimoto T; Masunaga T; Fujita M; Furukawa H; Uede T; Todo S
Transplantation; 2004 Nov; 78(10):1463-70. PubMed ID: 15599310
[TBL] [Abstract][Full Text] [Related]
18. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
19. Transfection of CD40Ig into liver prevents acute rejection in rat liver transplantation.
Zhu JY; Liu YN; Wang D; Li T; Leng XS
Transplant Proc; 2005 Dec; 37(10):4571-4. PubMed ID: 16387173
[TBL] [Abstract][Full Text] [Related]
20. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
